Scientists advance uses of lab-on-chip technology

MIT researchers have pushed the envelope on lab-on-a-chip technology that could significantly increase the vast array of chemical interactions that drug developers rely on to find new drug candidates. They have found that using intersecting channels to direct tiny bubbles on a microfluidic chip can replace the pumps and valves that have been in use. That switch would reduce the money spent in the discovery process and speed research. Experts say that dispensing with the pumps and valves makes the lab-on-a-chip far more compact. The new technology theoretically allows a researcher to test all the possible combinations of 20 different chemicals.

- read the report from MIT's Technology Review

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.